Redox State in the Course of Chronic Renal Insufficiency and Hemodialysis: Implications in Morbimortality
NCT ID: NCT00684034
Last Updated: 2014-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
131 participants
INTERVENTIONAL
2008-06-30
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxidative Stress on Muscle Dysfunction in Hemodialysis Patient
NCT02794142
Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients
NCT00692068
Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients
NCT01327391
Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera Hemodialysis Population
NCT02832323
Heparin-Free Chronic HemoDialysis Assessment
NCT06224140
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Volunteer healthy
Sampling of blood
A sampling of blood will be made
2
Patient dialysis patient
Sampling of blood
A sampling of bood will be made before the dialysis
3
Not dialysed chronic renal insufficient patient
Sampling of blood
A sampling of blood will be made.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sampling of blood
A sampling of blood will be made
Sampling of blood
A sampling of bood will be made before the dialysis
Sampling of blood
A sampling of blood will be made.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Rate of haemoglobin \> 11 g / dl
* Clinically stable patient that is having had no considerable event (cardiovascular problem, infection, surgical operation) with the exception of angioplasty of fistula or prosthesis vascular, in the previous 3 months the entrance to the study
* Patient capable of understanding and of following the essay, in particular knowing how to read the note of information.
Exclusion Criteria
* Treatment by corticoids or immunosuppresseurs
* hemopathy sly
* chronic cancer or infection in evolution
* Cardiovascular event (infarct, unstable angor, coronary bypasses, confusions of the rhythm, AVC, amputation) or infectious (blood-poisoning, pneumopathie, meningitis) or surgical operation in the previous 3 months the inclusion in the study.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bertrand DUSSOL, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hopitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital de la Conception- Service de Néphrologie et de transplantation rénale
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-38
Identifier Type: -
Identifier Source: secondary_id
2007-A01179-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.